Equity Profile

STE

STERIS plc

Health CareHealth Care Equipment$23.0B

Aug5Wed

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

STERIS plc is a leading provider of health care equipment and services, focusing on sterilization and infection prevention. With a market cap of $23 billion, the company plays a crucial role in ensuring patient safety and operational efficiency in healthcare settings.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet customer demand, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter, STERIS reported an EPS of $2.83, slightly missing estimates. The stock reacted negatively, dropping 2.70% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for STERIS's upcoming earnings are mixed, with no analyst estimates available. Investors are keen to see if the company can rebound from its recent earnings miss.

Bull Case

If STERIS beats EPS estimates and shows strong revenue growth, it could signal a recovery and renewed investor confidence.

Bear Case

Conversely, if STERIS misses expectations again or reports weak revenue growth, it could further dampen investor sentiment and lead to a larger sell-off.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for this quarter?

EPS is a critical measure of profitability, and a strong performance could help restore investor confidence after recent misses.

How does STERIS plan to address recent operational challenges?

Management's commentary on operational efficiency and growth strategies will be crucial for assessing future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating STERIS's ability to rebound from recent operational challenges, especially given its strong historical performance.

Supporting Evidence

The company's average EPS beat rate is 75%, indicating a strong track record of exceeding expectations.

Options pricing suggests a larger move than historical averages, indicating potential for volatility that could favor a rebound.

Insider buying activity, although minimal, suggests some confidence in the company's future performance.

Key Risk

If management provides strong guidance on operational improvements, it could shift market sentiment significantly.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized to see if STERIS can overcome recent challenges and meet or exceed expectations.

Bull Confirmed If

An EPS of $2.85 or higher would confirm a strong recovery and positive market sentiment.

Bear Confirmed If

An EPS below $2.70 would likely reinforce negative sentiment and concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a modest increase, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.

Miss

If STERIS misses again, history suggests a potential drop in stock price, as investor confidence may wane further.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Management's outlook on revenue growth for the upcoming quarters.
3Details on new product launches or market expansions.
4Insights into cost management strategies in light of recent challenges.
5Any commentary on competitive positioning in the health care equipment market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet customer demand, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter, STERIS reported an EPS of $2.83, slightly missing estimates. The stock reacted negatively, dropping 2.70% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for STERIS's upcoming earnings are mixed, with no analyst estimates available. Investors are keen to see if the company can rebound from its recent earnings miss.

Bull Case

If STERIS beats EPS estimates and shows strong revenue growth, it could signal a recovery and renewed investor confidence.

Bear Case

Conversely, if STERIS misses expectations again or reports weak revenue growth, it could further dampen investor sentiment and lead to a larger sell-off.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for this quarter?

EPS is a critical measure of profitability, and a strong performance could help restore investor confidence after recent misses.

How does STERIS plan to address recent operational challenges?

Management's commentary on operational efficiency and growth strategies will be crucial for assessing future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating STERIS's ability to rebound from recent operational challenges, especially given its strong historical performance.

Supporting Evidence

The company's average EPS beat rate is 75%, indicating a strong track record of exceeding expectations.

Options pricing suggests a larger move than historical averages, indicating potential for volatility that could favor a rebound.

Insider buying activity, although minimal, suggests some confidence in the company's future performance.

Key Risk

If management provides strong guidance on operational improvements, it could shift market sentiment significantly.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized to see if STERIS can overcome recent challenges and meet or exceed expectations.

Bull Confirmed If

An EPS of $2.85 or higher would confirm a strong recovery and positive market sentiment.

Bear Confirmed If

An EPS below $2.70 would likely reinforce negative sentiment and concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a modest increase, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.

Miss

If STERIS misses again, history suggests a potential drop in stock price, as investor confidence may wane further.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Management's outlook on revenue growth for the upcoming quarters.
3Details on new product launches or market expansions.
4Insights into cost management strategies in light of recent challenges.
5Any commentary on competitive positioning in the health care equipment market.